NEWRON PHARMACEUT. EO-20 historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2024-11-25 | 7.830 | 7.850 | 7.640 | 7.720 | 7.720 | 2,943 |
| 2024-11-22 | 7.780 | 7.970 | 7.740 | 7.970 | 7.970 | 3,131 |
| 2024-11-21 | 7.770 | 8.020 | 7.770 | 8.020 | 8.020 | 1,086 |
| 2024-11-20 | 7.670 | 7.760 | 7.550 | 7.760 | 7.760 | 9,937 |
| 2024-11-19 | 7.670 | 7.800 | 7.440 | 7.630 | 7.630 | 15,617 |
| 2024-11-18 | 7.980 | 7.980 | 7.270 | 7.520 | 7.520 | 3,154 |
| 2024-11-15 | 8.100 | 8.100 | 7.750 | 7.910 | 7.910 | 4,580 |
| 2024-11-14 | 8.000 | 8.200 | 7.910 | 8.170 | 8.170 | 6,259 |
| 2024-11-13 | 7.900 | 7.990 | 7.800 | 7.980 | 7.980 | 6,520 |
| 2024-11-12 | 8.210 | 8.210 | 7.940 | 8.000 | 8.000 | 7,567 |
| 2024-11-11 | 8.400 | 8.400 | 8.220 | 8.270 | 8.270 | 1,809 |
| 2024-11-08 | 8.460 | 8.510 | 8.390 | 8.390 | 8.390 | 1,294 |
| 2024-11-07 | 8.210 | 8.400 | 8.210 | 8.330 | 8.330 | 618 |
| 2024-11-06 | 8.500 | 8.500 | 8.200 | 8.250 | 8.250 | 2,346 |
| 2024-11-05 | 8.510 | 8.650 | 8.310 | 8.650 | 8.650 | 1,991 |
| 2024-11-04 | 8.860 | 8.860 | 8.480 | 8.600 | 8.600 | 470 |
| 2024-11-01 | 8.840 | 8.870 | 8.720 | 8.870 | 8.870 | 59 |
| 2024-10-31 | 8.650 | 8.730 | 8.570 | 8.570 | 8.570 | 6,098 |
| 2024-10-30 | 8.560 | 8.890 | 8.450 | 8.890 | 8.890 | 5,285 |
| 2024-10-29 | 9.080 | 9.080 | 8.850 | 8.860 | 8.860 | 3,080 |
| 2024-10-28 | 9.390 | 9.400 | 9.190 | 9.350 | 9.350 | 674 |
| 2024-10-25 | 9.150 | 9.320 | 9.150 | 9.300 | 9.300 | 2,391 |
| 2024-10-24 | 9.290 | 9.290 | 8.850 | 9.200 | 9.200 | 9,579 |
| 2024-10-23 | 9.420 | 9.470 | 9.340 | 9.350 | 9.350 | 3,453 |
| 2024-10-22 | 9.620 | 9.870 | 9.520 | 9.740 | 9.740 | 1,367 |
| 2024-10-21 | 9.520 | 9.990 | 9.490 | 9.560 | 9.560 | 9,792 |
| 2024-10-18 | 8.370 | 9.390 | 8.370 | 9.320 | 9.320 | 13,838 |
| 2024-10-17 | 8.420 | 8.520 | 8.410 | 8.450 | 8.450 | 2,194 |
| 2024-10-16 | 8.750 | 8.750 | 8.480 | 8.490 | 8.490 | 5,522 |
| 2024-10-15 | 8.550 | 8.590 | 8.350 | 8.590 | 8.590 | 18,754 |
| 2024-10-14 | 8.000 | 8.270 | 7.830 | 8.250 | 8.250 | 8,620 |
| 2024-10-11 | 7.820 | 7.880 | 7.820 | 7.840 | 7.840 | 1,728 |
| 2024-10-10 | 7.940 | 7.940 | 7.640 | 7.790 | 7.790 | 8,453 |
| 2024-10-09 | 8.200 | 8.200 | 7.780 | 8.010 | 8.010 | 14,890 |
| 2024-10-08 | 8.170 | 8.170 | 8.130 | 8.130 | 8.130 | 100 |
| 2024-10-07 | 8.270 | 8.270 | 8.070 | 8.070 | 8.070 | 4,011 |
| 2024-10-04 | 8.440 | 8.440 | 8.200 | 8.270 | 8.270 | 2,371 |
| 2024-10-03 | 8.340 | 8.490 | 8.300 | 8.490 | 8.490 | 1,291 |
| 2024-10-02 | 8.290 | 8.480 | 8.290 | 8.480 | 8.480 | 3,835 |
| 2024-10-01 | 8.430 | 8.460 | 8.290 | 8.290 | 8.290 | 2,292 |
| 2024-09-30 | 8.400 | 8.400 | 8.250 | 8.250 | 8.250 | 800 |
| 2024-09-27 | 8.050 | 8.300 | 8.050 | 8.290 | 8.290 | 1,370 |
| 2024-09-26 | 8.040 | 8.130 | 7.910 | 7.910 | 7.910 | 3,722 |
| 2024-09-25 | 7.950 | 8.480 | 7.730 | 7.910 | 7.910 | 22,077 |
| 2024-09-24 | 8.100 | 8.180 | 7.920 | 8.050 | 8.050 | 15,916 |
| 2024-09-23 | 8.500 | 8.500 | 8.000 | 8.110 | 8.110 | 20,295 |
| 2024-09-20 | 7.940 | 8.390 | 7.940 | 8.390 | 8.390 | 2,855 |
| 2024-09-19 | 8.290 | 8.520 | 8.000 | 8.170 | 8.170 | 12,509 |
| 2024-09-18 | 8.670 | 8.760 | 8.670 | 8.760 | 8.760 | 800 |
| 2024-09-17 | 8.790 | 8.790 | 8.790 | 8.790 | 8.790 | 52 |
| 2024-09-16 | 8.720 | 8.780 | 8.720 | 8.780 | 8.780 | 52 |
| 2024-09-13 | 8.330 | 8.680 | 8.290 | 8.590 | 8.590 | 3,463 |
| 2024-09-12 | 8.530 | 8.570 | 8.330 | 8.330 | 8.330 | 3,592 |
| 2024-09-11 | 8.460 | 8.460 | 8.310 | 8.310 | 8.310 | 1,400 |
| 2024-09-10 | 8.880 | 8.880 | 8.500 | 8.540 | 8.540 | 4,338 |
| 2024-09-09 | 8.530 | 8.580 | 8.380 | 8.560 | 8.560 | 2,332 |
| 2024-09-06 | 8.230 | 8.760 | 8.220 | 8.760 | 8.760 | 7,244 |
| 2024-09-05 | 8.870 | 8.870 | 8.070 | 8.220 | 8.220 | 13,515 |
| 2024-09-04 | 8.930 | 9.240 | 8.910 | 9.090 | 9.090 | 2,368 |
| 2024-09-03 | 9.290 | 9.500 | 9.010 | 9.100 | 9.100 | 5,346 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (EUR). Adjusted close accounts for splits and dividends. Educational only, not financial advice.